COVID-19
The U.S. has approved a new COVID-19 vaccine made by Moderna, with limitations on who can use it. The new vaccine, mNexspike, is a step towards next-generation coronavirus vaccines and is made with a lower dose, a fifth of the dose of Moderna's existing COVID-19 vaccine, Spikevax.
COVID-19
The Centers for Disease Control and Prevention (CDC) has made a significant shift in their vaccination recommendations, with Health and Human Services Secretary Robert F. Kennedy Jr. announcing that routine COVID-19 shots will no longer be recommended for pregnant women and healthy children. This decision has sparked concern among public
COVID-19
The US Department of Health and Human Services announced that the Covid-19 vaccine is no longer recommended for healthy children and pregnant women. This decision was announced by Robert F Kennedy Jr, who has been a vocal critic of widespread vaccination. The move reverses previous guidance from the Centers for
COVID-19
As of Tuesday, the US Centers for Disease Control and Prevention (CDC) has removed COVID-19 vaccines from its list of recommended immunizations for pregnant women and "healthy" children. This move comes after a joint announcement by the US Department of Health and Human Services (HHS) secretary Robert F.
COVID-19
In a drastic shift from the CDC's previous stance, the agency announced on May 27, 2025, that it will no longer recommend COVID-19 vaccines for healthy children and pregnant women. Secretary of Health and Human Services Robert F. Kennedy Jr. made the announcement, citing "common sense"
COVID-19
The US Food and Drug Administration (FDA) has unveiled a major policy shift in how COVID-19 vaccines are approved for annual use in the US. According to the new framework, healthy younger adults and children will no longer be routinely approved for annual COVID-19 shots. Instead, the FDA will require
COVID-19
The US Food and Drug Administration (FDA) is adopting a more nuanced approach to COVID-19 vaccine approvals, requiring robust evidence for certain groups to warrant future approvals. According to FDA Commissioner Marty Makary, M.D., and Center for Biologics Evaluation and Research (CBER) head Vinay Prasad, M.D., the agency&
COVID-19
The US Food and Drug Administration (FDA) has revealed plans to limit approval for updated COVID-19 vaccines, only allowing those over the age of 65 and individuals with certain health conditions to access the vaccine. The change is a departure from the agency's previous approach, which made the
COVID-19
The U.S. Food and Drug Administration has granted full approval to Novavax's COVID-19 vaccine, but only for certain groups. The vaccine, the only protein-based COVID vaccine available in the U.S., is approved for adults ages 65 and older, or for people ages 12 to 64 who
COVID-19
The U.S. Food and Drug Administration has approved Novavax's COVID-19 vaccine, however, its use is restricted to older adults and those with underlying conditions that put them at risk. This decision comes after a delay in the approval process and raises concerns about the vaccine's
Vaccination
Parents of children as young as six months old may soon be able to get their kids vaccinated against COVID-19, as Moderna has submitted an application to the FDA to authorize its vaccine for young children aged 6 months through five years. Clinical trials have shown the vaccine to be
Vaccination
U.S. President Joe Biden honored the Tampa Bay Lightning's back-to-back Stanley Cup championships at the White House on Monday, praising the team's vaccine efforts and being welcomed into the Oval Office by the President himself. The event marked a rare sports break for Biden amid
